Nourish Raises $100M Series C for Metabolic Health Platform

Nourish, a digital platform dedicated to improving metabolic health through accessible nutrition counseling, has successfully closed a $100 million Series C funding round. The financing was led by Menlo Ventures, signaling strong investor confidence in the company's approach to tackling chronic conditions like diabetes, obesity, and cardiovascular disease.

This significant capital infusion arrives at a pivotal moment for cardiometabolic care. With six in ten American adults managing at least one chronic condition, and associated healthcare costs exceeding a trillion dollars annually, the demand for effective, preventative interventions is escalating. Traditional approaches often fall short, leaving a critical gap in patient support. Nourish aims to bridge this divide by making evidence-based nutritional guidance readily available and covered by insurance.

The company's innovative model connects individuals with a vast network of over 10,000 registered dietitians nationwide. Nourish handles the administrative complexities, including credentialing, insurance verification, claims processing, and scheduling, allowing dietitians to focus on patient care. This streamlined process ensures that patients can access virtual sessions with minimal out-of-pocket expense and find a suitable provider within minutes. The platform's integration of AI further enhances efficiency, automating clinical documentation and surfacing insights from patient data.

A key driver for Nourish's growth has been its strategic outreach to physicians. The company has cultivated relationships with tens of thousands of referring providers, establishing itself as a trusted clinical-grade solution for metabolic health management. This physician engagement is particularly crucial as payers increasingly recognize that medication alone, such as GLP-1 prescriptions, is insufficient for long-term patient outcomes. Insurers are beginning to mandate dietitian involvement as a prerequisite for GLP-1 approvals, underscoring the value of integrated nutritional support.

Menlo Ventures, through partners JP Sanday, Greg Yap, Derek Xiao, and Sabrina Lu, highlighted their long-standing thesis around personalized, accessible, and insurance-covered healthcare solutions. They see Nourish as a critical component in this ecosystem, drawing parallels to the evolution of behavioral health services. The firm also pointed to its existing portfolio companies, including Grow Therapy, Function Health, Solace, Cartwheel, and Ophelia, as examples of their commitment to transforming care delivery across various health domains.

With this new funding, Nourish plans to expand its services beyond nutrition counseling. Future initiatives include integrating GLP-1 prescribing support, laboratory services, and comprehensive chronic care management. This strategic expansion positions Nourish to evolve into a holistic, longitudinal care partner, addressing the full spectrum of a patient's health journey rather than isolated health events. The company's founders, Aidan, Stephanie, and Sam, bring a deep understanding of the challenges in accessing care, driving their mission to build a more effective and equitable system.